Yasuo Kansui Selected Research

Yasuo Kansui Research Topics

Disease

11	Hypertension (High Blood Pressure) 01/2019 - 07/2004
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 02/2006
3	Stroke (Strokes) 06/2007 - 05/2004
1	Apnea 01/2018
1	Reperfusion Injury 08/2017
1	Ischemia 08/2017
1	Inflammation (Inflammations) 08/2017
1	Obesity 01/2014
1	Insulin Resistance 01/2014
1	Alzheimer Disease (Alzheimer's Disease) 05/2013
1	Alkalosis 05/2013
1	Respiratory Acidosis 05/2013
1	Muscle Weakness 05/2013
1	Hypokalemia 05/2013
1	Liddle Syndrome 05/2013
1	Diabetes Mellitus 02/2006
1	Essential Hypertension 01/2005
1	Hyperaldosteronism (Conn Syndrome) 01/2005

Drug/Important Bio-Agent (IBA)

3	endothelium-dependent hyperpolarization factor (EDHF)IBA 02/2006 - 07/2004
2	Uric Acid (Urate)IBA 01/2018 - 01/2011
2	PotassiumIBA 05/2013 - 01/2005
2	Fluvastatin FDA Link 08/2006 - 05/2004
2	Antihypertensive Agents (Antihypertensives)IBA 09/2004 - 07/2004
1	C-Reactive ProteinIBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2018
1	HDL CholesterolIBA 01/2018
1	Angiotensin II Type 1 Receptor BlockersIBA 10/2017
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2017
1	Valsartan (Vals)FDA Link 10/2017
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2017
1	Neprilysin (Neutral Endopeptidase)IBA 10/2017
1	Allopurinol (Remid)FDA LinkGeneric 08/2017
1	3-nitrotyrosineIBA 08/2017
1	Xanthine DehydrogenaseIBA 08/2017
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2017
1	LipidsIBA 01/2014
1	Yi-Gan SanIBA 05/2013
1	Plant ExtractsIBA 05/2013
1	ChloridesIBA 05/2013
1	Cortisone FDA Link 05/2013
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2013
1	11-beta-Hydroxysteroid Dehydrogenase Type 2 (11 beta-Hydroxysteroid Dehydrogenase Type 2)IBA 05/2013
1	SodiumIBA 05/2013
1	SaltsIBA 08/2012
1	8-oxodeoxyguanosine triphosphateIBA 06/2007
1	DNA (Deoxyribonucleic Acid)IBA 06/2007
1	8-Hydroxy-2'-DeoxyguanosineIBA 06/2007
1	Proteins (Proteins, Gene)FDA Link 06/2007
1	rho-Associated KinasesIBA 08/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2006
1	Angiotensin Receptor AntagonistsIBA 02/2006
1	Vasodilator Agents (Vasodilators)IBA 02/2006
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2004
1	Enalapril FDA LinkGeneric 09/2004
1	Type 1 Angiotensin ReceptorIBA 09/2004
1	candesartanIBA 09/2004
1	ConnexinsIBA 07/2004